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procedure on our patients for purely scientific reasons outside the
context of indicated biopsies .
All rejection episodes were International Society in Heart and
Lung Transplantation grade 3A and greater, and baseline was
considered grade 0 to 1 . Blood samples were not taken during
surgery and there was no evidence of active viral infection at the
time of cytokine measurement . Active infection was an exclusion
criterion for inclusion of data into the study .
We believe that our study does not prejudice the further devel-
opment of monoclonal antibodies, mainly because Jennison et al .
misunderstand the aim of our study . This was an observational
study to examine which cytokines are being released and only
secondarily to correlate these cytokines with rejection . The study
does not have the power to address the latter question, We should
have stated that there is no obvious relation between a particular
cytokine and rejection ; this does not imply that a relation does not
exist . In fact, our Figure 7 suggests that a relation may well exist .
We believe that documenting that a number of cytokines other than
IL-2 receptor (Ref . 3 to 8 of Dennison et al .) are being release(] from
the cardiac allograft (and not irom some unknown peripheral site)
provides exciting new potential therapeutic options .
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Pulmonary Embolism After CardWc Surgery
I was impressed by the unusually high incidence of pulmonary
embolism after cardiac operations in the report by Josa and associ-
ates (1) . Their retrospective data led logically to the conclusion that
the incidence of pulmonary embolism in the patients undergoing
coronary artery bypass grafting (3 .9%) is higher than that (3%)
reported by Kakkar et al . (2) in a prospective study of patients
undergoing general surgical operations . However, I feel uncomfort-
able with their conclusion because we recently reported different
results (3) on the same issue .
In our report (3), we reviewed the clinical records of 4,393
patients who underwent cardiac surgery requiring cardiopulmonary
bypass at a large university hospital between January 1984 and
December 1988 . Of these, only 13 patients developed venous
thromboembolism postoperatively . There were eight cases of deep
vein thrombosis and five of pulmonary embolism . Three of the
patients with pulmonary embolism underwent coronary artery by-
pass grafting and two had aortic valve replacement . Pulmonary
embolism accounted for the death of one patient . Follow-up data
were available in all patients and averaged 38 ± 5 .6 months (range 2
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Figure 1 . Survival rate and incidence of deep vein thrombosis
(DVT) and pulmonary embolism (PE) in 4,393 patients who under-
went cardiac surgery requiring cardiopulmonary hospital at a large
university hospital between January 1984 and December 1988 .
Reprinted, with permission, from Canver and Fiedler (3) .
to 72) . Actuarial survival at 5 years was 92% after a cardiac
operation (Fig . 1) .
Our observations agree with their proposed risk factors of
prolonged immobility, obesity and previous deep vein thrombosis .
However, the incidence of venous thromboembolism after open
heart surgery was 0 .3% in our series (3) . The increasing use of
intravenous and oral anticoagulant agents before open heart surgery
and the routine use of platelet suppressant therapy may offer
possible explanations for the observed low occurrence of postoper-
ative pulmonary embolism in this subset of patients . Based on our
experience, it appears that the 3 .9% incidence of pulmonary embo-
lism among cardiac surgical patients is extremely high .
In many cases of pulmonary embolism occurring after general
surgical operations, deep vein thrombosis is the most common
source for dislodgment of a clot in the pulmonary circuit . It is
unclear why the incidence of deep vein thrombosis is very low iii
pulmonary embolism cases in the series of Josa and associates (I) .
This discrepancy requires explanation .
Limitations of retrospective studies on this complex issue em-
phasize the need for a randomized prospective study to investigate
the true incidence of venous thromboembolic complications after
cardiac surgery .
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Reply
Canver's letter raises two important issues : the incidence of deep
vein thrombosis and pulmonary embolism after cardiac surgery .
With respect to the first, it was not the aim of our study to determine
the incidence of deep vein thrombosis in patients undergoing cardiac
surgery . Although deep vein thrombosis precedes pulmonary em-
bolism, it is usually asymptomatic and can be detected only by
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objective testing. Reis et al . (1) recently reported a 44
.8% incidence
rate of deep vein thrombosis (documented by B-mode ultrasonog-
raphy) in patients undergoing coronary bypass surgery ; none of
these patients had symptoms of deep vein thrombosis . In our study,
6 of the 32 patients who developed pulmonary embolism had
symptoms of deep vein thrombosis . It is conceivable that deep vein
thrombosis was silent in the remainder and might have been
detected had we employed an invasive or noninvasive test to
diagnose the condition .
The few published reports on pulmonary embolism (2.-6) indicate
an incidence rate of 0,3% to 9.5%. The difference in the incidence
rate reported by us (3 .910) and by Canver (0.3%) has three possible
explanations . 1) Canver did not separate the group with isolated
valve surgery (in which we did not find any postoperative pulmonary
embolism) from the overall cardiac surgical group, as we did in our
study, 2) It appears that Canver selected only those patients whose
ventilation-perfusion lung scan indicated a high probability of em-
bolism; 9 of our 32 patients had indeterminate or low probability
ventilation-perfusion lung scans in which pulmonary embolism was
confirmed by pulmonary angiography . 3) When we found initially (7)
that a significant number of patients undergoing coronary bypass
surgery developed postoperative pulmonary embolism, we kept a
low threshold for diagnosing the condition subsequently . However,
we agree with Canver that only a systematic, prospective study can
conclusively establish the incidence and magnitude of this important
complication of coronary bypass surgery .
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Determination of Mitral Regurgitant Flow
ate m Color Flow Maps of the
e ur i nt Flow Convergence 'Region
Recently Chen et al
. (1) used the flow convergence method as
described by Recusani et al . (2) to determine mitral regurgitant flow
rate. The radius rte, of the isovelocity shells was imaged by color
r study in the two-dimensional and M-r .iode approaches .
Regurgitant flow rate, Q, was calculated as
Q = 2 art, 1 2 v,
where v is the velocity defining the isovelocity shell
. As described in
detail, the mean systolic regurgitant flow rate, Qmean, was calcu-
lated as
Qmean = 2 r (q, rmean)- v .
We believe that this approach is not logical because the square of the
mean is not the same as the mean of the squares . Rather it would be
conclusive to calculate Qmean as
Qmean = 2 ir (r(vla)mean v .
The values for Qmean determined by the investigators overesti-
mate their reference values with an excellent correlation between
the two . With regard to the variability of the reference method, this
correlation could probably not be any better . If the correct calcula-
tion is applied, generally higher values for Qmean must result, so
that this overestimation must increase and the correlation is most
likely to decrease . Probably the much simpler to measure maximal
regurgitant flow rate would then show a closer association to the
reference values than would Qmean .
The reference values were measured by a combined pulsed wave
Dopplerltwo-dimensional echocardiographic method as described
earlier by others. These reference values (up to 225 ml(beat) also
appear to represent an overestimation, as they are higher than invasive
d;sla (up to 119 to 156 mI/beat) from the published reports (3-5) .
In summary, these color Doppler mapping-derived values for
tral regurgitant flow rate probably represent a considerable over-
estimation. Invasive data (angiographic Fick method) would have
disclosed this and should therefore be included in such studies, as
reported by others (5,6). The results show no advantage of color
M-mode study over two-dimensional color Doppler study for the
11uw convergence method in mitral regurgitation .
MARTIN GIESLER, MD
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Reply
Most of the questions and comments of Giesler and Hombach have
been discussed in detail in our article . The rationale for calculating
mean proximal accelerating flow rate instead of simply using maxi-
ntai accelerating flow rate was to serve the main purpose of our
article (1), which was to examine whether the calculated proximal
accelerating flow rate differed from the regurgitant flow rate . Be-
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